Oral l-arginine improves endothelial dysfunction in patients with essential hypertension

Lekakis, J; Papathanassiou, S; Papaioannou, T; Papamichael, C; Zakopoulos, N; Kotsis, V; Dagre, A; Stamatelopoulos, K; Protogerou, A; Stamatelopoulos, S

dc.contributor.author	Lekakis, J	en
dc.contributor.author	Papathanassiou, S	en
dc.contributor.author	Papaioannou, T	en
dc.contributor.author	Papamichael, C	en
dc.contributor.author	Zakopoulos, N	en
dc.contributor.author	Kotsis, V	en
dc.contributor.author	Dagre, A	en
dc.contributor.author	Stamatelopoulos, K	en
dc.contributor.author	Protogerou, A	en
dc.contributor.author	Stamatelopoulos, S	en
dc.date.accessioned	2014-03-01T01:51:42Z
dc.date.available	2014-03-01T01:51:42Z
dc.date.issued	2002	en
dc.identifier.uri	https://dspace.lib.ntua.gr/xmlui/handle/123456789/26392
dc.subject	Blood Lipids	en
dc.subject	Blood Pressure	en
dc.subject	Body Mass Index	en
dc.subject	Coronary Artery Disease	en
dc.subject	Endothelial Dysfunction	en
dc.subject	Endothelial Function	en
dc.subject	Essential Hypertension	en
dc.subject	Flow Mediated Dilation	en
dc.subject	Intima Media Thickness	en
dc.subject	Long-term Effect	en
dc.subject	Nitric Oxide	en
dc.subject	Oral Administration	en
dc.subject	Brachial Artery	en
dc.subject	Blood Flow	en
dc.subject	Common Carotid Artery	en
dc.subject	Heart Rate	en
dc.title	Oral l-arginine improves endothelial dysfunction in patients with essential hypertension	en
heal.type	journalArticle	en
heal.identifier.primary	10.1016/S0167-5273(02)00413-8	en
heal.identifier.secondary	http://dx.doi.org/10.1016/S0167-5273(02)00413-8	en
heal.publicationDate	2002	en
heal.abstract	Background:l-Arginine is a nitric oxide precursor, which augments endothelium-dependent vasodilatation in hypercholesterolemic humans and animals. Endothelium-dependent vasodilation is attenuated in patients with hypertension; however the effects of oral l-arginine on endothelial function of the conduit arteries in patients with essential hypertension have not previously been investigated. Methods: In a prospective randomized double blind trial, 35 patients with essential hypertension received	en
heal.journalName	International Journal of Cardiology	en
dc.identifier.doi	10.1016/S0167-5273(02)00413-8	en